These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 9830054

  • 1. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.
    Letamendía A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C.
    J Biol Chem; 1998 Dec 04; 273(49):33011-9. PubMed ID: 9830054
    [Abstract] [Full Text] [Related]

  • 2. Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling.
    Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskirchen R.
    J Biol Chem; 2005 Jan 28; 280(4):3078-87. PubMed ID: 15537649
    [Abstract] [Full Text] [Related]

  • 3. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors.
    Wong SH, Hamel L, Chevalier S, Philip A.
    Eur J Biochem; 2000 Sep 28; 267(17):5550-60. PubMed ID: 10951214
    [Abstract] [Full Text] [Related]

  • 4. Endoglin modulates cellular responses to TGF-beta 1.
    Lastres P, Letamendía A, Zhang H, Rius C, Almendro N, Raab U, López LA, Langa C, Fabra A, Letarte M, Bernabéu C.
    J Cell Biol; 1996 Jun 28; 133(5):1109-21. PubMed ID: 8655583
    [Abstract] [Full Text] [Related]

  • 5. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
    Lux A, Attisano L, Marchuk DA.
    J Biol Chem; 1999 Apr 09; 274(15):9984-92. PubMed ID: 10187774
    [Abstract] [Full Text] [Related]

  • 6. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H, Shaw AR, Mak A, Letarte M.
    J Immunol; 1996 Jan 15; 156(2):564-73. PubMed ID: 8543807
    [Abstract] [Full Text] [Related]

  • 7. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts.
    Obreo J, Díez-Marques L, Lamas S, Düwell A, Eleno N, Bernabéu C, Pandiella A, López-Novoa JM, Rodríguez-Barbero A.
    Cell Physiol Biochem; 2004 Jan 15; 14(4-6):301-10. PubMed ID: 15319534
    [Abstract] [Full Text] [Related]

  • 8. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
    Parker WL, Goldring MB, Philip A.
    J Bone Miner Res; 2003 Feb 15; 18(2):289-302. PubMed ID: 12568406
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
    Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, Findlay JK.
    Endocrinology; 2007 Nov 15; 148(11):5355-68. PubMed ID: 17656464
    [Abstract] [Full Text] [Related]

  • 10. Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function.
    Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG.
    J Biol Chem; 2002 Jan 04; 277(1):823-9. PubMed ID: 11668175
    [Abstract] [Full Text] [Related]

  • 11. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C.
    J Biol Chem; 2002 Aug 09; 277(32):29197-209. PubMed ID: 12015308
    [Abstract] [Full Text] [Related]

  • 12. Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.
    Fukushima D, Bützow R, Hildebrand A, Ruoslahti E.
    J Biol Chem; 1993 Oct 25; 268(30):22710-5. PubMed ID: 8226781
    [Abstract] [Full Text] [Related]

  • 13. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma.
    Jindal SK, Ishii E, Letarte M, Vera S, Teerds KJ, Dorrington JH.
    Biol Reprod; 1995 May 25; 52(5):1027-37. PubMed ID: 7626702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
    Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M.
    J Biol Chem; 1992 Sep 25; 267(27):19027-30. PubMed ID: 1326540
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.
    Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, López-Casillas F.
    J Biol Chem; 2001 May 04; 276(18):14588-96. PubMed ID: 11278442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.
    López-Casillas F, Payne HM, Andres JL, Massagué J.
    J Cell Biol; 1994 Feb 04; 124(4):557-68. PubMed ID: 8106553
    [Abstract] [Full Text] [Related]

  • 20. CD105 inhibits transforming growth factor-beta-Smad3 signalling.
    Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S.
    Anticancer Res; 2004 Feb 04; 24(3a):1337-45. PubMed ID: 15274293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.